Prohibiting Tianeptine and Other Dangerous Products Act of 2026
Sponsor
Full profile: /officials/D000563
Source: Congress.gov · FEC
Cosponsors (1)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S512)
2026-02-05
Source: Congress.gov
Plain-English Summary
This bill would ban the sale and distribution of tianeptine, a drug sometimes sold as a dietary supplement or nootropic that can cause addiction and serious health problems, along with other potentially dangerous products. The ban would apply to retailers, online sellers, and manufacturers who currently market these substances to consumers. The legislation aims to protect public health by preventing access to drugs that lack proper FDA approval and oversight.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- SRES799A resolution expressing the condolences of the Senate and honoring the memory of the victims on the fourth anniversary of the mass shooting at the Fourth of July parade in Highland Park, Illinois, on July 4, 2022.Referred to Committee · 2026-07-15
- S4979PROMISE Act of 2026Referred to Committee · 2026-07-14
- S4955A bill to amend the Act of May 17, 1954, to revise the boundary of Gateway Arch National Park.Referred to Committee · 2026-07-13
- S1146Cameras in the Courtroom ActReported by Committee · 2026-06-23